These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Schroeder M, Mass MJ. Biochem Biophys Res Commun; 1997 Jun 18; 235(2):403-6. PubMed ID: 9199206 [Abstract] [Full Text] [Related]
28. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822 [Abstract] [Full Text] [Related]
30. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM, Rao JS. Oncogene; 2006 Aug 03; 25(33):4559-72. PubMed ID: 16786000 [Abstract] [Full Text] [Related]
31. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Melki JR, Vincent PC, Clark SJ. Cancer Res; 1999 Aug 01; 59(15):3730-40. PubMed ID: 10446989 [Abstract] [Full Text] [Related]
35. Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5' CpG island. Huang Y, Peng J, Oberley LW, Domann FE. Free Radic Biol Med; 1997 Aug 01; 23(2):314-20. PubMed ID: 9199894 [Abstract] [Full Text] [Related]
36. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Newell-Price J, King P, Clark AJ. Mol Endocrinol; 2001 Feb 01; 15(2):338-48. PubMed ID: 11158338 [Abstract] [Full Text] [Related]
37. De novo CpG island methylation in human cancer cells. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee I, Yen RW, Baylin SB, Schuebel KE. Cancer Res; 2006 Jan 15; 66(2):682-92. PubMed ID: 16423997 [Abstract] [Full Text] [Related]